In studies including additional expression of CD138, a marker associated with plasma cell differentiation, high CD20 together with CD138 expression correlated with a higher tumor grade in epithelial ovarian cancer and immune cell-associated CD138 expression alone with poorer overall and cancer-specific patient survival (Lundgren et al., 2016). This evidence concerns the gene SDC1 and neoplasm.